Ronot M, Cauchy F, Gregoli B et al (2016) Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden. HPB (Oxford) 18(8):684–690

Article  PubMed  Google Scholar 

Schnitzbauer AA, Lang SA, Goessmann H et al (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414

Article  PubMed  Google Scholar 

Zhang GQ, Zhang ZW, Lau WY, Chen XP (2014) Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery. Int J Surg 12(5):437–441

Article  PubMed  Google Scholar 

Lang H, de Santibañes E, Schlitt HJ et al (2019) 10th Anniversary of ALPPS-Lessons Learned and quo Vadis. Ann Surg 269(1):114–119

Article  PubMed  Google Scholar 

Chan A, Zhang WY, Chok K et al (2021) ALPPS versus portal vein embolization for hepatitis-related hepatocellular carcinoma: a changing paradigm in modulation of future liver remnant before major hepatectomy. Ann Surg 273(5):957–965

Article  PubMed  Google Scholar 

Truant S, El Amrani M, Baillet C et al (2019) Laparoscopic partial ALPPS: much better than ALPPS! Ann Hepatol 18(1):269–273

Article  PubMed  Google Scholar 

Abulkhir A, Limongelli P, Healey AJ et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57

Article  PubMed  Google Scholar 

Gruttadauria S, Luca A, Mandala L, Miraglia R, Gridelli B (2006) Sequential preoperative ipsilateral portal and arterial embolization in patients with colorectal liver metastases. World J Surg 30(4):576–578

Article  PubMed  Google Scholar 

Simoneau E, Aljiffry M, Salman A et al (2012) Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford) 14(7):461–468

Article  PubMed  Google Scholar 

Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26(5):1474–1493

Article  PubMed  Google Scholar 

Xu X, Zhang HL, Liu QP et al (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70(6):1133–1144

Article  PubMed  Google Scholar 

Murata S, Tajima H, Nakazawa K, Onozawa S, Kumita S, Nomura K (2009) Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts. Eur Radiol 19(8):2016–2023

Article  PubMed  Google Scholar 

Xu C, Lv PH, Huang XE et al (2014) Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev 15(2):703–706

Article  PubMed  Google Scholar 

Finn RS, Qin S, Ikeda M et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382(20):1894–1905

Article  CAS  PubMed  Google Scholar 

Chao J, Zhu Q, Chen D et al (2021) Case report: transarterial chemoembolization in combination with tislelizumab downstages unresectable hepatocellular carcinoma followed by radical salvage resection. Front Oncol 11:667555

Article  PubMed  PubMed Central  Google Scholar 

Wu JY, Yin ZY, Bai YN et al (2021) Lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a multicenter retrospective study. J Hepatocell Carcinoma 8:1233–1240

Article  PubMed  PubMed Central  Google Scholar 

Vilgrain V, Pereira H, Assenat E et al (2017) Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol 18(12):1624–1636

Article  CAS  PubMed  Google Scholar 

Pamecha V, Sasturkar SV, Sinha PK et al (2017) Major liver resection for large and locally advanced hepatocellular carcinoma. Indian J Surg 79(4):326–331

Article  PubMed  Google Scholar 

Chen XP, Hu DY, Zhang ZW et al (2007) Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma. Dig Surg 24(3):208–213

Article  CAS  PubMed  Google Scholar 

Yoo H, Kim JH, Ko GY et al (2011) Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 18(5):1251–1257

Article  PubMed  Google Scholar 

Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713–724

Article  PubMed  Google Scholar 

Yagi S, Iida T, Hori T et al (2006) Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation 81(3):373–378

Article  PubMed  Google Scholar 

Stockmann M, Bednarsch J, Malinowski M et al (2017) Functional considerations in ALPPS—consequences for clinical management. HPB (Oxford) 19(11):1016–1025

Article  PubMed  Google Scholar 

Olthof PB, Tomassini F, Huespe PE et al (2017) Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: liver volume overestimates liver function. Surgery 162(4):775–783

Article  PubMed  Google Scholar 

Zhang J, Huang H, Bian J et al (2020) Safety, feasibility, and efficacy of associating liver partition and portal vein ligation for staged hepatectomy in treating hepatocellular carcinoma: a systematic review. Ann Transl Med 8(19):1246

Article  PubMed  PubMed Central  Google Scholar 

Goumard C, Komatsu S, Brustia R, Fartoux L, Soubrane O, Scatton O (2017) Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study. Surg Endosc 31(5):2340–2349

Article  PubMed  Google Scholar 

Wang Z, Peng Y, Hu J et al (2020) Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of 45 patients. Ann Surg 271(3):534–541

Article  PubMed  Google Scholar 

Robles-Campos R, Navarro-Barrios Á, Martínez-Caceres C et al (2020) The contribution of the deportalized lobe to liver regeneration in tourniquet-ALPPS. Ann Surg 271(3):e94–e96

Article  PubMed  Google Scholar 

Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V (2006) Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93(9):1091–1098

Article  CAS  PubMed  Google Scholar 

Cui L, Liu XX, Jiang Y et al (2012) Comparative study on transcatheter arterial chemoembolization, portal vein embolization and high intensity focused ultrasound sequential therapy for patients. Asian Pac J Cancer Prev 13(12):6257–6261

Article  PubMed  Google Scholar 

Wu B, Zhou J, Ling G, Zhu D, Long Q (2018) CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study. World J Surg Oncol 16(1):69

Article  PubMed  PubMed Central  Google Scholar 

Song MJ, Chun HJ, Song DS et al (2012) Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 57(6):1244–1250

Article  CAS  PubMed  Google Scholar 

Zhang S, Huang C, Li Z et al (2017) Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers. Drug Deliv 24(1):1011–1017

Article  PubMed  PubMed Central  Google Scholar 

Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474–481

Article  CAS  PubMed  Google Scholar 

Llovet JM, De Baere T, Kulik L et al (2021) Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 18(5):293–313

Article  CAS  PubMed  Google Scholar 

Kudo M, Ueshima K, Ikeda M et al (2020) Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut 69(8):1492–1501

Article  PubMed  Google Scholar 

Yi M, Jiao D, Qin S, Chu Q, Wu K, Li A (2019) Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment. Mol Cancer 18(1):60

Article  PubMed  PubMed Central  Google Scholar 

Hoekstra LT, van Lienden KP, Doets A, Busch OR, Gouma DJ, van Gulik TM (2012) Tumor progression after preoperative portal vein embolization. Ann Surg 256(5):812–817; discussion 817–818

Zhu XD, Li KS, Sun HC (2020) Adjuvant therapies after curative treatments for hepatocellular carcinoma: current status and prospects. Genes Dis 7(3):359–369

Article  CAS